The Female-Biased Factor VGLL3 Drives Cutaneous and Systemic Autoimmunity.
Allison C. Billi,Mehrnaz Gharaee‐Kermani,Joseph Fullmer,Lam C. Tsoi,Brett Hill,Dennis Gruszka,J. Ludwig,Xianying Xing,Shannon N Estadt,Sonya Wolf,Syed Rizvi,Céline C. Berthier,Jeffrey B. Hodgin,Maria A. Beamer,Mrinal K. Sarkar,Yun Liang,Rattapon Uppala,Shuai Shao,Chang Zeng,Paul W. Harms,Monique Verhaegen,John J. Voorhees,Fei Wen,Nicole L. Ward,Andrzej A. Dlugosz,J. Michelle Kahlenberg,Jóhann E. Guðjónsson
DOI: https://doi.org/10.1172/jci.insight.127291
IF: 9.4958
2019-01-01
JCI Insight
Abstract:Autoimmune disease is 4 times more common in women than men. This bias is largely unexplained. Female skin is "autoimmunity prone," showing upregulation of many proinflammatory genes, even in healthy women. We previously identified VGLL3 as a putative transcription cofactor enriched in female skin. Here, we demonstrate that skin-directed overexpression of murine VGLL3 causes a severe lupus-like rash and systemic autoimmune disease that involves B cell expansion, autoantibody production, immune complex deposition, and end-organ damage. Excess epidermal VGLL3 drives a proinflammatory gene expression program that overlaps with both female skin and cutaneous lupus. This includes increased B cell-activating factor (BAFF), the only current biologic target in systemic lupus erythematosus (SLE); IFN-κ, a key inflammatory mediator in cutaneous lupus; and CXCL13, a biomarker of early-onset SLE and renal involvement. Our results demonstrate that skin-targeted overexpression of the female-biased factor VGLL3 is sufficient to drive cutaneous and systemic autoimmune disease that is strikingly similar to SLE. This work strongly implicates VGLL3 as a pivotal orchestrator of sex-biased autoimmunity.